vTv Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	98.5	36.75	9.45	12.13	13.42	5.75
Short-Term Investments	-	0.09	0.07	0.02	0.1	0.37
Cash & Short-Term Investments	98.5	36.83	9.51	12.14	13.52	6.12
Cash Growth	136.47%	287.25%	-21.66%	-10.17%	120.91%	201.83%
Accounts Receivable	-	0.06	0.1	0.17	0.06	0.16
Other Receivables	-	-	-	-	0.14	-
Receivables	-	0.06	0.1	12.42	0.19	0.16
Prepaid Expenses	0.84	1.22	1.04	2.54	1.91	0.94
Total Current Assets	99.46	38.11	10.66	27.09	15.62	7.22
Property, Plant & Equipment	0.04	0.15	0.36	0.56	0.68	0.85
Long-Term Investments	-	-	-	5.59	9.17	6.73
Total Assets	99.49	38.27	11.02	33.24	25.47	14.79
Accounts Payable	9.8	0.94	4.08	2.46	1.88	1.93
Accrued Expenses	-	4.09	6.17	4.85	6.15	4.2
Short-Term Debt	0.33	-	0.19	0.22	0.26	0.08
Current Portion of Leases	0.03	0.17	0.17	0.15	0.18	0.16
Current Unearned Revenue	-	-	0.02	0.02	0.04	0.03
Total Current Liabilities	10.16	5.2	10.62	7.71	8.5	6.39
Long-Term Leases	-	-	0.17	0.34	0.49	0.68
Long-Term Unearned Revenue	18.67	18.67	18.67	18.67	-	1.01
Other Long-Term Liabilities	0.12	0.1	0.11	0.68	1.26	2.92
Total Liabilities	28.95	23.97	29.57	27.4	10.25	11
Common Stock	0.04	0.03	0.03	0.03	0.9	0.77
Additional Paid-In Capital	390.06	311.89	256.34	254.76	238.19	209.16
Retained Earnings	-319.55	-299.72	-281.04	-265.52	-248.83	-290.04
Total Common Equity	70.54	12.2	-24.68	-10.74	-9.74	-80.1
Minority Interest	-	2.1	6.13	16.58	24.96	83.9
Shareholders' Equity	70.54	14.3	-18.55	5.84	15.22	3.79
Total Liabilities & Equity	99.49	38.27	11.02	33.24	25.47	14.79
Total Debt	0.36	0.17	0.53	0.72	0.93	0.92
Net Cash (Debt)	98.14	36.66	8.98	11.43	12.58	5.2
Net Cash Growth	136.82%	308.17%	-21.38%	-9.20%	141.84%	-
Net Cash Per Share	14.11	6.35	4.31	5.95	8.03	4.42
Filing Date Shares Outstanding	12.41	6.58	2.43	2.04	1.67	1.44
Total Common Shares Outstanding	12.41	6.58	2.08	2.04	1.67	1.35
Working Capital	89.29	32.92	0.04	19.39	7.12	0.83
Book Value Per Share	5.68	1.85	-11.84	-5.27	-5.82	-59.28
Tangible Book Value	70.54	12.2	-24.68	-10.74	-9.74	-80.1
Tangible Book Value Per Share	5.68	1.85	-11.84	-5.27	-5.82	-59.28
Machinery	-	0.12	0.12	0.12	0.1	0.1
Leasehold Improvements	-	0.41	0.41	0.41	0.41	0.41

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q